Your browser doesn't support javascript.
loading
Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.
Crutcher, Madison M; Snook, Adam E; Waldman, Scott A.
Affiliation
  • Crutcher MM; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Snook AE; Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA.
  • Waldman SA; Department of Microbiology & Immunology, Thomas Jefferson University, Philadelphia, PA, USA.
Expert Rev Clin Pharmacol ; 15(11): 1317-1326, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36259230
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacology, Clinical / Colorectal Neoplasms Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacology, Clinical / Colorectal Neoplasms Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2022 Document type: Article Affiliation country: